Hypertension Trial, Recruiting (NCT06266260)

Hypertension Trial, Recruiting NCT06266260 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT06266260 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been newly diagnosed with swollen veins in your esophagus or stomach (called varices), or there are signs suggesting high blood pressure in the vein that supplies your liver (confirmed by scans, blood tests, or other non-invasive tests)
You have not previously taken a type of medication called non-selective beta-blockers (such as propranolol or carvedilol) for this condition

Who may not be able to join:

Your liver disease is at a more advanced stage than a mild level, as measured by a scoring system called Child-Pugh (confirm with trial site)
You have been diagnosed with liver cancer (hepatocellular carcinoma)
You have a blood clot blocking the main vein leading to your liver (called portal vein thrombosis)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Francesco Santopaolo, MD, Fondazione Policlinico A. Gemelli IRCCS, Rome

Phone: +393492754288

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06266260

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase: Not Applicable

Status: Recruiting

Condition: Hypertension

Trial contact: +393492754288

More information: https://clinicaltrials.gov/study/NCT06266260

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been newly diagnosed with swollen veins in your esophagus or stomach (called varices), or there are signs suggesting high blood pressure in the vein that supplies your liver (confirmed by scans, blood tests, or other non-invasive tests)
You have not previously taken a type of medication called non-selective beta-blockers (such as propranolol or carvedilol) for this condition

Who may not be able to join:

Your liver disease is at a more advanced stage than a mild level, as measured by a scoring system called Child-Pugh (confirm with trial site)
You have been diagnosed with liver cancer (hepatocellular carcinoma)
You have a blood clot blocking the main vein leading to your liver (called portal vein thrombosis)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Registry

ClinicalTrials.gov

Start date

11 September 2023

Est. completion

1 April 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Measurement of the portal pressure gradient though endoscopic ultrasound (EUS) and hepatic venous pressure gradient (HVPG) to evaluate the hemodynamic response to non-selective beta blockers (NSBBs); HVPG Measurement Before and After NSBB Titration in Portal Hypertension

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov